Granuloma Annulare

• CLINICAL_TRIALS withdrawal · 2025-04-29
  Clinical Trial Update: Tyrosine Kinase 2 (TYK2) for GA and CS [Phase 2]

  A Phase 2 trial evaluating a TYK2-targeted therapy for sarcoidosis and granuloma annulare was withdrawn.

• CLINICAL_TRIALS research · 2025-03-04
  Clinical Trial Update: Janus Kinase Inhibition in Granuloma Annulare [Phase 2]

  A Phase 2 clinical trial evaluating a Janus kinase inhibitor for granuloma annulare is currently active but not recruiting.

• CLINICAL_TRIALS trial_result · 2024-10-15
  Clinical Trial Update: Study to Evaluate the Safety and Tolerability of AC-1101 Topical Gel in Patients with Granuloma Annulare [Phase 1]

  Phase 1 study evaluating the safety and tolerability of AC-1101 topical gel in patients with granuloma annulare has been completed.

• CLINICAL_TRIALS trial_result · 2024-04-30
  Clinical Trial Update: Granuloma Annulare Treated With Rifampin, Ofloxacin, and Minocycline Combination Therapy

  A completed clinical trial evaluated a rifampin/ofloxacin/minocycline combination therapy for granuloma annulare.

• CLINICAL_TRIALS trial_result · 2015-07-27
  Clinical Trial Update: UVA1 Light for Scleroderma and Similar Conditions [NA]

  A University of Michigan-sponsored UVA1 light therapy trial for scleroderma and related conditions (keloid, scars, granuloma annulare, acne …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2015-05-01
  Clinical Trial Update: Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix [Phase 1, Phase 2]

  This clinical trial update reports the completion of Phase 1 and Phase 2 studies evaluating ultraviolet B (UVB) light therapy for skin condi…